Today: 12 April 2026
Subscribe

SoFi Stock Soars 171% to Record Highs on Breakout Earnings – Will the Rally Continue? (Nov 2025 Update)

SoFi Stock Soars 171% to Record Highs on Breakout Earnings – Will the Rally Continue? (Nov 2025 Update)

SoFi Technologies stock surged 171% year-over-year, hitting a record $32.57 in late October before settling near $29–30 on November 5. Q3 2025 net revenue reached $962 million, up 38%, with net income of $139 million. Management raised 2025 revenue guidance to $3.5–3.54 billion and EPS to $0.37. Membership climbed to 12.6 million, up 35% from a year ago.
5 November 2025
··
Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?

Pfizer Stock Plunge and Promise: Vaccine Slump, Weight-Loss War, and a $10B Gamble – Is PFE Poised for a Comeback?

Pfizer closed at $24.45 on Nov. 5, 2025, with a market cap near $138 billion, more than 60% below its pandemic-era peak. Q3 revenue fell 6% to about $16.7 billion, while adjusted earnings beat forecasts at $0.87 per share. COVID-19 product sales continued to drop sharply. Pfizer is in a bidding war with Novo Nordisk for obesity drug developer Metsera.
5 November 2025
··
Cipher Mining Stock Skyrockets on Blockbuster AWS Deal – Latest Earnings, Expert Insights & Price Forecast

Cipher Mining Stock Skyrockets on Blockbuster AWS Deal – Latest Earnings, Expert Insights & Price Forecast

Cipher Mining shares surged over 22% in a day and climbed 30% in a week after announcing a $5.5 billion, 15-year AWS data center deal and posting a surprise Q3 profit. The company reported $72 million in Q3 revenue and $0.10 adjusted EPS, beating expectations. Cipher also launched a West Texas data center project and completed a $1.3 billion convertible note offering. Analyst price targets rose to as high as $33.
5 November 2025
··
Rubico (RUBI) Stock in Freefall: Top Ships Spin-Off Collapses 90% – What Investors Should Know

Rubico (RUBI) Stock in Freefall: Top Ships Spin-Off Collapses 90% – What Investors Should Know

Rubico Inc. shares plunged 55% to $0.29 on Nov. 5, 2025, after announcing a $7.5 million dilutive offering, leaving its market cap below $2 million. The Greek tanker spin-off operates two Suezmax crude oil vessels on long-term charters but faces high debt and low liquidity. Retail traders remain bullish despite a 90% drop from its August debut. No institutional ownership or analyst coverage reported.
5 November 2025
·
First Majestic Silver (AG) Shines on Silver’s Surge – But Can the Rally Sustain?

First Majestic Silver (AG) Shines on Silver’s Surge – But Can the Rally Sustain?

First Majestic Silver shares fell 8.5% to $10.57 on November 5 after Q3 earnings missed estimates, despite record revenue of $285.1 million and net income of $43 million. Trading volume surged to 12.8 million shares. The Los Gatos mine contributed 45% of revenue, while all-in sustaining costs dropped to $20.90/oz. The company ended Q3 with $568.8 million in treasury and declared a $0.0052 dividend.
5 November 2025
·
Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook

Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook

Rigel Pharmaceuticals shares jumped over 30% to around $38 on Nov. 5, 2025, after reporting Q3 revenue of $69.5 million, up 25% year-over-year. Net income reached $27.9 million, and the company raised its 2025 revenue guidance to $285–$290 million. Product sales, led by Tavalisse, surged 65%. Rigel also announced new clinical milestones and ongoing global partnerships.
5 November 2025
··
Lumentum Stock Skyrockets on AI Boom – Record Sales & Bold Forecast

Lumentum Stock Skyrockets on AI Boom – Record Sales & Bold Forecast

Lumentum reported record fiscal Q1 2026 revenue of $533.8 million, up 58% year-over-year, and returned to profit with $4.2 million net income after a loss last year. Shares surged as much as 20% to a 52-week high near $227 following bullish Q2 guidance and strong AI-driven demand. Over 60% of revenue now comes from cloud and AI infrastructure. Wall Street raised price targets, citing accelerating growth.
5 November 2025
··
Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense shares fell to the mid-$70s after Q3 revenue beat estimates but Q4 guidance missed forecasts, cutting market cap to $13 billion. The company announced a $356.3 million cash acquisition of Israel’s Orbit Technologies and raised 2025 revenue guidance. Year-to-date, the stock is up over 300%, hitting a 21-year high in October. Analyst consensus is “Moderate Buy” with targets ranging from $77 to $125.
5 November 2025
···
Babcock & Wilcox (BW) Stock Skyrockets on AI Power Deal – Key Facts, Q3 Earnings & 2025 Outlook

Babcock & Wilcox (BW) Stock Skyrockets on AI Power Deal – Key Facts, Q3 Earnings & 2025 Outlook

Babcock & Wilcox shares jumped nearly 40% to $5.19 on Nov. 5 after announcing a $1.5 billion AI data center power project with Applied Digital. The company posted a smaller Q3 net loss of $2.3 million and sold its A-S-H business for $29 million, using proceeds to redeem $26 million in debt. BW also launched a $200 million at-the-market stock sale. Analysts upgraded the stock but flagged ongoing liquidity risks.
5 November 2025
·····
Trex Stock Plunges on Earnings Miss – What’s Next for the Decking Leader?

Trex Stock Plunges on Earnings Miss – What’s Next for the Decking Leader?

Trex Company shares plunged about 25% in early November 2025 after missing Q3 earnings estimates and cutting full-year guidance, hitting multi-year lows in the mid-$30s. Analysts downgraded the stock and slashed price targets following the report. Q3 revenue reached $285 million, up 22% year-over-year, but management cited weak demand and margin pressure. Trading volume spiked as the stock broke below key support levels.
5 November 2025
···
From Crash to Breakthrough: Why Lunai Bioworks (LNAI) Is Suddenly on Investors’ Radar

From Crash to Breakthrough: Why Lunai Bioworks (LNAI) Is Suddenly on Investors’ Radar

Lunai Bioworks (NASDAQ: LNAI) shares surged over 15% to around $1 after announcing preclinical success in pancreatic cancer immunotherapy on Nov. 5, 2025. The stock remains down more than 85% year-over-year and trades near all-time lows after a 10:1 reverse split in September. Lunai is pre-revenue, posted a $178 million net loss over the past year, and faces severe liquidity issues.
5 November 2025
···
Biohaven (BHVN) Stock Plunges on FDA Setback – Will Its Biotech Pipeline Fuel a Comeback?

Biohaven (BHVN) Stock Plunges on FDA Setback – Will Its Biotech Pipeline Fuel a Comeback?

Biohaven Ltd. shares plunged about 40% on Nov. 5, 2025, after the FDA rejected its lead drug VYGLXIA for spinocerebellar ataxia, citing trial design and data issues. The company will cut R&D spending by 60% and halt non-priority programs. Analysts downgraded the stock, which now trades near $8–9, down over 70% year-over-year. Biohaven reported a $198 million net loss in Q2 with $408 million in cash.
5 November 2025
·
Why Zeta Global (ZETA) Stock Is Soaring: 17 Straight Beats, AI Power, and Big Upside Ahead

Why Zeta Global (ZETA) Stock Is Soaring: 17 Straight Beats, AI Power, and Big Upside Ahead

Zeta Global reported Q3 2025 revenue of $337.2 million, up 26% year-over-year, with adjusted EPS and operating margin both beating expectations. Shares surged about 15% on November 5, nearing $19. Management raised full-year guidance and forecast continued strong growth for 2026. The company agreed to acquire Marigold’s enterprise marketing business for $325 million, its largest deal to date.
5 November 2025
···
Digital Turbine’s Wild 2025 Ride: APPS Stock Soars 300% on Mobile Ad Comeback – What Investors Need to Know

Digital Turbine’s Wild 2025 Ride: APPS Stock Soars 300% on Mobile Ad Comeback – What Investors Need to Know

Digital Turbine shares surged 34% to around $8.00 on Nov. 5, 2025, after beating Q2 FY2026 earnings and raising guidance. The stock is up 379% year-to-date and 156% year-over-year, rebounding from a 52-week low of $1.18. Market capitalization stands near $900 million. The company provides mobile advertising software pre-installed on over 1 billion devices worldwide.
5 November 2025
·
SMX (Security Matters) PLC Stock Rockets on Supply Chain Tech Breakthroughs – Can the 2025 Comeback Last?

SMX (Security Matters) PLC Stock Rockets on Supply Chain Tech Breakthroughs – Can the 2025 Comeback Last?

SMX shares jumped about 50% to $2.30 on Nov. 5, 2025, after announcing a partnership with Spanish research center CARTIF. The stock had plunged over 81% in late October, hitting an all-time low near $1.45, following a 1-for-10.9 reverse split and ongoing losses. SMX remains unprofitable, reporting a $44 million net loss over the past year. The company specializes in digital supply chain tracking using molecular markers and blockchain.
5 November 2025
···
Recursion Pharmaceuticals (RXRX) – AI Drug Discovery Breakthroughs, CEO Shakeup & 2025 Stock Outlook

Recursion Pharmaceuticals (RXRX) – AI Drug Discovery Breakthroughs, CEO Shakeup & 2025 Stock Outlook

Recursion Pharmaceuticals shares fell 15% in the past week to around $5, down 55% from their 52-week high. Q3 2025 revenue missed estimates at $5 million, with net loss widening to $162.3 million. The company announced a $30 million milestone payment from Roche/Genentech and a CEO transition, with Najat Khan set to take over in January. Recursion holds about $785 million in cash, enough to fund operations through 2027.
5 November 2025
··
Intel Stock Rollercoaster: Big Rally, CEO Shake-Up, and AI Ambitions Fuel 2025 Outlook

Intel Stock Rollercoaster: Big Rally, CEO Shake-Up, and AI Ambitions Fuel 2025 Outlook

Intel shares fell 6% Wednesday, ending their biggest five-day rally, but remain up over 80% year-to-date and near a 52-week high around $39. Q3 revenue beat forecasts at $13.7 billion, and a $5 billion Nvidia investment in September sent the stock up 23% in one day. CEO Pat Gelsinger was ousted in late 2024, replaced by Lip-Bu Tan, who cut 16% of staff. The U.S. government and SoftBank also took major stakes.
5 November 2025
·
Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Technologies’ shares have surged over 150% in 2025, hitting an all-time high near $207 before a post-earnings dip to the upper-$180s. Q3 revenue soared 63% to $1.18 billion, with U.S. commercial sales more than doubling. The company posted $0.18 GAAP EPS and $540 million in free cash flow. Michael Burry disclosed a large bearish bet, while Jim Cramer raised his price target to $200.
5 November 2025
···
The Surprising Upside in CCC Intelligent Solutions (CCCS): Why This Under-the-Radar SaaS Stock Could Soar

The Surprising Upside in CCC Intelligent Solutions (CCCS): Why This Under-the-Radar SaaS Stock Could Soar

CCC Intelligent Solutions reported Q3 2025 revenue of $267.1 million, up 12% year-over-year, with adjusted EBITDA of $110 million, but posted a $2 million net loss due to higher costs. Liberty Mutual signed on to shift much of its casualty claims to CCC’s platform, and the company raised its 2025 revenue guidance. Shares trade near a 52-week low at $8.30, down 35% from the high.
5 November 2025
·
1 … 1,575 1,576 1,577 1,578 1,579 … 1,848

Stock Market Today

  • Invesco Price Target Cut by 12.17% to €26.13 Amid Mixed Institutional Moves
    April 12, 2026, 8:35 AM EDT. Invesco's (BIT:1IVZ) average one-year price target fell by 12.17% to €26.13, down from €29.75. Despite the drop, the target still indicates a 32.25% rise from the current €19.76 share price. Institutional holdings decreased 10.36% in the past quarter, with 631 funds reporting positions-a 41.95% decline in owners. Notable shifts include Millennium Management boosting shares by 7.31%, while Aqr Capital slashed holdings by 10.54%. Massachusetts Mutual Life Insurance maintained steady at 18.31% ownership. Average portfolio weight across funds rose 8.35% to 0.21%. The mixed changes reflect cautious fund sentiment as analysts adjust outlooks on Invesco's stock.

Latest article

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

12 April 2026
Bitcoin fell 1.4% to $71,707 on Sunday after U.S.-Iran talks in Islamabad ended without a deal. Spot bitcoin ETFs logged net inflows last week, with BlackRock and Fidelity leading Friday’s buying. Morgan Stanley launched its MSBT fund on April 8, the first Wall Street bank to debut a bitcoin ETF. U.S. inflation data showed headline CPI up 3.3% in March, while core CPI rose 2.6%.
XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

12 April 2026
XRP slipped about 1% to $1.33 on Sunday after U.S.-Iran peace talks in Islamabad ended without a deal, pressuring crypto markets. The token traded in a narrow range, with bitcoin and ether also weaker. XRP’s market cap stands at $81.7 billion, with $1.96 billion in daily volume. The token remains 63.5% below its all-time high.
Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

12 April 2026
Spot gold steadied at $4,761.79 an ounce Friday after a third weekly gain, with U.S. futures at $4,787.40. The dollar posted its biggest weekly drop since January, making gold cheaper for non-U.S. buyers. U.S.-Iran talks ended without a deal, keeping geopolitical risks high. China’s central bank increased gold reserves for a 17th month, reaching 74.38 million ounces.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Go toTop